However, factors such as increasing Food and Drug Administration (FDA) recalls is hindering
the cephalosporin drugs market growth. For instance, in June 2019, Lupin Limited recalled
18,604 bottles (60 ml) of Cefdinir (Cephalosporin) for Oral Suspension, used for the treatment of
bacterial infections, from the U.S. market. Furthermore, in January 2019, the company
announced recall of 287,784 bottles of Cefdinir for Oral Suspension in the U.S. due to CGMP
(Current Good Manufacturing Practice) deviations.
Browse Complete Report For More Information @
https://www.coherentmarketinsights.com/market-insight/cephalosporin-drugs-market-2893
Key players operating in the global cephalosporin drugs market include, Merck & Co. Inc.,
GlaxoSmithKline plc., Pfizer Inc., Allergan plc., Abbott Laboratories, Basilea Pharmaceutica Ltd.,
Sanofi S.A., F. Hoffmann-La Roche AG, Lupin Limited, Teva Pharmaceutical Industries Ltd., and
B. Braun Melsungen AG.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-
ready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com